Researchers Develop New Duo-Targeting Drug for Aggressive Leukemias (UF Health)
UF Health Cancer Institute researchers have created a novel drug that effectively killed aggressive leukemia cells by targeting two proteins that promote the cancer’s growth.
Novel Compound Opens New Avenue in Immunotherapy Treatment for Cancers
Researchers at the UF Health Cancer Center have developed a first-of-it-kind compound that may reveal a new way to treat cancer using immunotherapy. Currently, immunotherapy is among the most groundbreaking cancer treatments, but only about 20% to 40% of patients respond to it. It works by first identifying a target protein that contributes to tumor development and then developing a compound that will target that protein specifically, slowing tumor growth and boosting the body’s immune system to fight off the cancer.